Monica Hollstein

A Novel p53 Mutant Found in Iatrogenic Urothelial Cancers Is Dysfunctional and Can Be Rescued by a Second-site Global Suppressor Mutation*

Hiba Alogheli, M. Hollstein, A. Odell, 2013, The Journal of Biological Chemistry.

TP53 mutations in human cancers: origins, consequences, and clinical use.

Magali Olivier, Pierre Hainaut, M. Olivier, 2010, Cold Spring Harbor perspectives in biology.

p53 polymorphisms: cancer implications

Paul D. P. Pharoah, P. Pharoah, M. Hollstein, 2009, Nature Reviews Cancer.

TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data

Dmitriy Sonkin, Jiri Zavadil, Maude Ardin, 2016, Human mutation.

Massively regulated genes: the example of TP53

Pierre Hainaut, M. Hollstein, P. Hainaut, 2010, The Journal of pathology.

Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue.

Matthias Kretzler, Hermann-Josef Gröne, Marc Kenzelmann, 2002, The American journal of pathology.